???global.info.a_carregar???
I graduated in Biology in the Faculty of Sciences of the University of Porto. This was followed by a Master Degree in Oncobiology in the Faculty of Medicine of the University of Porto and a PhD degree in the same Faculty in 2000. Both Master and PhD studies were performed in collaboration between the Institute of Molecular Pathology and Immunology of the University of Porto (Ipatimup) and the University of Copenhagen, in the group of Professor Henrik Clausen, a world leader in the gycobiology field. From 2001 until 2004, I was a Post-Doc at Ipatimup, studying the transcriptional mechanisms involved in intestinal metaplasia, a preneoplastic lesion of the stomach. Since the Masters until the end of the Post-doc I had fellowships from the Portuguese Foundation of Science and Technology. Since 2004 I hold a tenure position as Researcher, first as Assistant researcher (until 2020) and later on as Principal researcher. In 2013, I established my group “Differentiation and cancer” focusing on transcriptional and post-transcriptional regulatory mechanisms involved in gastrointestinal cancer progression and therapy resistance. I have been involved in multiple teaching activities within the University of Porto, in Master and PhD courses, in the field of Oncobiology. Since 2013, I am Invited Assistant Professor at the Department of Biology in the Faculty of Sciences of University of Porto, where I am also involved in undergraduate courses, as lecturer, mainly in the field of molecular and cellular biology. In 2015, I moved with my research group to the Institute of Research in Health and Innovation (i3S), the largest biomedical research institute in Portugal that resulted from the fusion of three institutes of the University of Porto, one of them being Ipatimup. I was member of the Scientific Council of Ipatimup (until 2015) and since 2015 I am member of the Scientific Council of I3S. I have been elected as vice-coordinator of the Cancer research program at i3S (2023-2026 mandate). From 2012 until 2016 I was President of the first fiscal council of The Portuguese Association for Cancer Research (ASPIC) and currently, I am ASPIC Ambassador. I participate in two COST Actions, EPITRAN (2017-2021) where I was member of the management committee and currently TRANSLACORE (2022-2026). I have coordinated 9 scientific projects (3 financed by FCT) and participated in 28. I have a long-standing experience in researcher supervision (2 Junior researchers and 6 postdocs) and in student supervision (11 PhD and 20 master students). I have published 79 papers and have an H Index = 35.
Read full resume ↓
Identification

Personal identification

Full name
Raquel Maria da Silva Graça Almeida

Citation names

  • Almeida, Raquel

Author identifiers

Ciência ID
1813-08A3-87B9
ORCID iD
0000-0002-5622-1633

Email addresses

  • ralmeida@ipatimup.pt (Professional)

Telephones

Mobile phone
  • 966147626 (Personal)
Telephone
  • 220408800 (Professional)

Addresses

  • Rua Alfredo Allen, 208 , 4200-135, Porto, Porto, Portugal (Professional)

Websites

Knowledge fields

  • Medical and Health Sciences - Basic Medicine

Languages

Language Speaking Reading Writing Listening Peer-review
Portuguese Advanced (C1) Advanced (C1) Advanced (C1) Advanced (C1)
English Advanced (C1) Advanced (C1) Advanced (C1) Advanced (C1)
French Intermediate (B1) Intermediate (B1) Intermediate (B1) Intermediate (B1)
Education
Degree Classification
2000
Concluded
 Doutoramento em Biologia Humana (Doutoramento)
Universidade do Porto Faculdade de Medicina, Portugal
"Identification and characterization of a human Beta4Galactosyltransferase gene family" (THESIS/DISSERTATION)
 Aprovada por unanimidade (nota máxima)
1996
Concluded
 Mestrado em Oncobiologia (Mestrado)
Universidade do Porto Faculdade de Medicina, Portugal
"Establishment of a strategy using expressed sequence tags (ESTs) to characterize genes expressed in human gastric tissues and gastric carcinoma cell lines." (THESIS/DISSERTATION)
 Muito Bom (nota máxima)
1994
Concluded
 Biologia (Licenciatura)
Universidade do Porto Faculdade de Ciências, Portugal
"Não se aplica" (THESIS/DISSERTATION)
 15/20
Affiliation

Science

Category
Host institution 		Employer
2020/04/01 - Current Principal Investigator (Research) Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal
Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal
2004/07/01 - 2020/03/31 Auxiliary Researcher (Research) Universidade do Porto Instituto de Patologia e Imunologia Molecular, Portugal
Universidade do Porto Instituto de Patologia e Imunologia Molecular, Portugal
2000/11/01 - 2004/06/30 Postdoc (Research) Universidade do Porto Instituto de Patologia e Imunologia Molecular, Portugal
Universidade do Porto Instituto de Patologia e Imunologia Molecular, Portugal

Teaching in Higher Education

Category
Host institution 		Employer
2013/12/01 - Current Invited Assistant Professor (University Teacher) Universidade do Porto Faculdade de Ciências, Portugal
Universidade do Porto Faculdade de Ciências, Portugal
2014 - 2021 Invited Assistant Professor (University Teacher) Universidade do Porto Faculdade de Medicina, Portugal
Projects

Grant

Designation Funders
2022/01/01 - 2024/12/31 diffNET - Restituir a diferenciação das células tumorais manipulando proteínas de ligação ao ARN
PTDC/BIA-CEL/0456/2021
Researcher
Fundação para a Ciência e a Tecnologia, Portugal
Ongoing
2022/01/01 - 2024/06/30 ResistNET - Identifying RNA-binding proteins mediating therapy resistance regulatory networks in cancer
NA
Researcher
Merck et Cie, Switzerland
Ongoing
2021/01/01 - 2023/06/30 Cancer Research on Therapy Resistance: From Basic Mechanisms to Novel Targets
NORTE-01-0145-FEDER-000051
Researcher
Comissao de Coordenacao e Desenvolvimento Regional do Norte, Portugal
2018/07/01 - 2021/06/30 ReProgram_Reconstructing the Program of Cancer Stem Cells
PTDC/MED-ONC/29017/2017
Principal investigator
Universidade do Porto Instituto de Patologia e Imunologia Molecular, Portugal
 Fundação para a Ciência e a Tecnologia
Ongoing
2018/07/01 - 2021/06/30 OVABLOCK: Blocking MUC16-mesothelin interaction to abrogate peritoneal metastization of ovarian cancer
POCI-01-0145-FEDER-029503
Researcher
Universidade do Porto Instituto de Patologia e Imunologia Molecular, Portugal
 Fundação para a Ciência e a Tecnologia
Ongoing
2017/01/01 - 2020/12/31 Cancel-Stem
POCI-01-0145-FEDER-016390
Researcher
Universidade do Porto Instituto de Patologia e Imunologia Molecular, Portugal
 Fundação para a Ciência e a Tecnologia
Ongoing
2018/07/01 - 2020/06/30 inSTEM: A novel post-transcriptional regulatory network controlling intestinal stem cells fate
POCI-01-0145-FEDER-031538
Researcher
Universidade do Porto Instituto de Patologia e Imunologia Molecular, Portugal
 Fundação para a Ciência e a Tecnologia
Ongoing
2016/05/01 - 2019/12/31 Advancing cancer research: from basic knowledge to application
NORTE–01–0145–FEDER–000029
Researcher
Universidade do Porto Instituto de Patologia e Imunologia Molecular, Portugal
 Comissao de Coordenacao e Desenvolvimento Regional do Norte
Concluded
2016/05/01 - 2019/12/31 Diabetes & obesity at the crossroads between Oncological and Cardiovascular diseases – a system analysis NETwork towards precision medicine (DOCnet)
NORTE–01–0145–FEDER–000003
Researcher
Comissao de Coordenacao e Desenvolvimento Regional do Norte
Concluded
2015/01/01 - 2016/12/31 StaTreat – Statins in gastric cancer treatment
StaTreat
Principal investigator
2014/01/01 - 2015/12/31 Establishment of a knock-out mouse for MEX3A
MEX3A
Principal investigator
2013/01/01 - 2015/12/31 Differentiation in cancer with emphasis on glycoproteome alterations
Project P11-Norte-01-0124-FEDER-000024
Researcher
Concluded
2011/01/01 - 2014/03/31 Mucin MUC16 - CA125 cancer biomarker – biological functions and development of new biomarker assays
PTDC/SAU-ONC/117216/2010
Researcher
Fundação para a Ciência e a Tecnologia
2012/01/01 - 2013/12/31 Modulating CDX2 expression in vivo using a nanoparticle-based strategy to deliver siRNAs
Nano
Principal investigator
Concluded
2008/01/01 - 2011/12/31 Identification of signaling pathways mediated by MUC1 oncogene in gastric carcinoma cell lines and immortalized gastric normal cells
PTDC/SAU-OBD/65616/2006
Researcher
Fundação para a Ciência e a Tecnologia
Concluded
2008/01/01 - 2011/03/31 Autoregulação do CDX2 na reversibilidade/irreversibilidade da metaplasia intestinal gástrica
PTDC/SAU-OBD/64490/2006
Principal investigator
Fundação para a Ciência e a Tecnologia
Concluded
2007/01/01 - 2010/07/31 Secretor and Lewis phenotypes/genotypes in Helicobacter pylori and calicivirus infection
PTDC/SAU-MII/64153/2006
Researcher
Fundação para a Ciência e a Tecnologia
Concluded
2005/01/01 - 2008/12/31 Identificação de genes associados a glicosilação induzidos em células gástricas pelo Helicobacter pylori: “Glicómica”
POCTI/SAU-OBS/56686/2004
Researcher
Fundação para a Ciência e a Tecnologia
2003/01/01 - 2006/12/31 Clarification of the biological role of MUC1 mucin variability in gastric carcinogenesis
POCTI/CBO/44812/2002
Researcher
Fundação para a Ciência e a Tecnologia
2003/01/01 - 2006/11/30 Molecular mechanisms of biosynthesis of altered mucin O-glycosylation in intestinal metaplasia
POCTI/CBO/44598/2002
Researcher
Fundação para a Ciência e a Tecnologia
2002/01/01 - 2005/12/31 Regulation of aberrant MUC2 mucin gene expression in intestinal metaplasia, mucinous gastric carcinomas and gastric carcinoma cell lines: role of methylation and putative trascription factors
POCTI/CBO/39075/2001;
Researcher
Fundação para a Ciência e a Tecnologia
Concluded
2001/07/01 - 2004/06/30 CDX1 AND CDX2 IN GASTRIC CARCINOGENESIS: ROLE ON ABERRANT DIFFERENTIATION WITH AN EMPHASIS ON ABERRANT MUCIN EXPRESSION
SFRH/BPD/5609/2001
 Fundação para a Ciência e a Tecnologia
Concluded
1997/01/01 - 2000/12/31 Characterization of genes expressed in gastric cells using expressed sequence tags
PRAXIS XXI – 2/2.1/BIA/276/94
Other
Fundação para a Ciência e a Tecnologia
Concluded
1996/11/01 - 2000/10/31 STUDY OF GENE EXPRESSION IN HUMAN GASTRIC TISSUES USING EXPRESSED SEQUENCE TAGS ESTs WITH EMPHASIS IN THE CHARACTERIZATION OF MUCIN RELATED GENES
PRAXIS XXI/BD/9468/96
 Fundação para a Ciência e a Tecnologia
Concluded

Contract

Designation Funders
2023/02/01 - 2025/01/31 Novel faecal biomarkers for early detection of precancerous lesions and Cancer: Improving the current model for colorectal cancer screening
2022.09051.PTDC
10.54499/2022.09051.PTDC
Researcher
Instituto Português de Oncologia do Porto Francisco Gentil EPE, Portugal

Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal
Fundação para a Ciência e a Tecnologia
Concluded
2011/01/01 - 2012/12/31 Strategic Project - LA 3 - 2011-2012
PEst-C/SAU/LA0003/2011
Universidade do Porto Instituto de Patologia e Imunologia Molecular, Portugal
 Fundação para a Ciência e a Tecnologia
Concluded
2007/09/01 - 2010/08/31 In vitro and in vivo manipulation of the expression of Sialyl Lewis X and E-cadherin in canine malignant mammary tumours.
PTDC/CVT/65537/2006
Universidade do Porto Instituto de Patologia e Imunologia Molecular, Portugal
 Fundação para a Ciência e a Tecnologia
Concluded
2005/07/01 - 2008/06/30 Genes associated to intestinal metaplasia of the gastric mucosa (MUC2 mucin and fucosyltransferase FUT3): regulation of transcription and role in Helicobacter pylori adhesion.
POCI/SAU-OBS/55549/2004
Universidade do Porto Instituto de Patologia e Imunologia Molecular, Portugal
 Fundação para a Ciência e a Tecnologia
Concluded
2005/07/01 - 2008/06/30 Identification of signaling pathways involved in Cdx2 regulation in two human models of altered intestinal differentiation: intestinal metaplasia and juvenile polyposis.
POCI/SAU-OBS/55840/2004
Universidade do Porto Instituto de Patologia e Imunologia Molecular, Portugal
 Fundação para a Ciência e a Tecnologia
Concluded

Other

Designation Funders
2017/10/01 - 2021/12/31 EPITRAN – European Epitranscriptomics Network
CA16120
Other
Universidade do Porto Instituto de Patologia e Imunologia Molecular, Portugal
 European Commission
Ongoing
Outputs

Publications

Conference abstract
  1. de Oliveira, Catarina V.; Ferreira, Diana; Luis F.C. Póvoas; Valentini, Elvia; Mesquita, Patricia; Pereira, B.; Jerónimo, Carmen; Almeida, Raquel. "Reading between the strands: the role of YTHDF3 in gastric cancer characterization". Paper presented in EMBO Workshop: The Epitranscriptome, (cancelled due to COVID-19), 2021.
  2. Ribeirinho, Sara; Mesquita, Patricia; Freire, Ana Filipa; Pádua, Diana; Coelho, Ricardo; Marques, Cristiana; Barros, Rita; et al. "SOX2 as a predictive biomarker of resistance to therapy in stage II CRC patients". Paper presented in Annual meeting of the Instituto de Investigação e Inovação em Saúde that took place 29th and 30th of November 2018 at the Axis Vermar Conference & Beach Hotel in Póvoa de Varzim, Portugal, Porto, 2018.
    Published
  3. Ribeirinho, Sara; Mesquita, Patricia; Marques, Cristiana; Barros, Rita; Amaral, Ana Luísa; Azevedo, Diana; Freire, Ana Filipa; David, Leonor; Almeida, Raquel. "SOX2 predicts stage II CRC patient response to adjuvant chemotherapy". Paper presented in Third international congress of the Portuguese Association of Cancer Research (ASPIC) hat took place in 10th and 11st of May at the Gulbenkian Foundation, Lisbon, Portugal,, Lisboa, 2018.
    Published
  4. Peleteiro, B; Barros, R.; Carrilho, C; Figueiredo, Ceu; Almeida, Raquel; David, L; Lunet, N. "Association between Helicobacter pylori infection and environmental risk factors for gastric cancer and the occurrence of CDX2 expression in Mozambique". Paper presented in IEA-EEF European Congress of Epidemiology, Florença, 2010.
    Published
Conference poster
  1. Pádua, Diana; Ribeiro, Inês; Freire, A; Almeida, Raquel; Mesquita, Patrícia. "HMGA1 rises the expression of Key reprogramming transcription factors in a non-CSC colon population". 2022.
  2. Ferreira, Diana; Amaral, Ana Luísa; Valentini, E.; de Oliveira, CV; Luis F.C. Póvoas; Mesquita, Patricia; Almeida, Raquel. "Identification of new biomarkers in gastric cancer - the role of epitranscriptomics". Paper presented in Young Researchers of the University of Porto, 2020.
  3. Luis F.C. Póvoas; Coelho, Ricardo; Ferreira, Diana; Valentini, Elvia; de Oliveira, Catarina V.; Mesquita, Patricia; Pereira, Bruno; Almeida, Raquel. "The epitranscriptome in gastric cancer: the role of m6A mRNA modifications". Paper presented in 13.º Encontro de Jovens Investigadores da U.PORTO, 2020.
  4. Henriques, Taciane; Santos, Diandra dos; Guimaraes, Isabella; Tessarollo, Nayara; Lyra, Paulo; Mesquisa, Patricia; Pádua, Diana; et al. "Abstract A133: Role of CXCR2 in the acquisition of pan-resistant phenotype in high grade serous ovarian cancer cells". Paper presented in AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, Hynes Convention Center, Boston, Massachusetts, Estados Unidos da América, 2019.
    10.1158/1535-7163.targ-19-a133
  5. Pereira B.; Dias, Alexandre; A. L. Amaral; N. Mendes; V. Muncan; A. R. Silva; C. Thibert; et al. "Mex3a deletion impairs Lgr5+ stem cell maintenance in the mouse gut". Paper presented in ISSCR International Symposium 2019: Stem cells and Organoids in Development and Disease, 2019.
  6. Dias, Alexandre; Amaral A. L.; Almeida, Raquel; Pereira B.. "Characterization of MEX3A RNA-binding protein in the mouse stomach.". Paper presented in VIII National RNA meeting: ptRNA, 2019.
  7. Ribeirinho, Sara; Mesquita, Patricia; Freire, Ana Filipa; Pádua, Diana; Coelho, Ricardo; Marques, Cristiana; Barros, Rita; et al. "SOX2 as a predictive biomarker of resistance to therapy in stage II CRC patients (speaker)". Paper presented in Annual meeting of the Instituto de Investigação e Inovação em Saúde that took place 29th and 30th of November 2018 at the Axis Vermar Conference & Beach Hotel in Póvoa de Varzim, Portugal, 2018.
  8. Ribeirinho, Sara; Mesquita, Patricia; Marques, Cristiana; Barros, Rita; Amaral, Ana Luísa; Azevedo, Diana; Freire, Ana Filipa; David, Leonor; Almeida, Raquel. "SOX2 predicts stage II CRC patients response to adjuvant chemotherapy (speaker)". Paper presented in Third international congress of the Portuguese Association of Cancer Research (ASPIC) that took place in 10th and 11st of May at the Gulbenkian Foundation, Lisbon, Portugal,, 2018.
    10.1158/1538-7445.am2015-5274
  9. Pádua, Diana; Barros, Rita; Almeida, Raquel. "Isolation and characterization of gastric cancer stem cells based on SOX2/OCT4 activity". Paper presented in IJUP 10ª edição – Encontro de Investigação Jovem Universidade do Porto, Faculty of Medicine of the University of Porto (FMUP), Porto, Portugal, 2017.
  10. Coelho, Ricardo; Marcos-Silva, Lara; Almeida, Raquel; Clausen, Henrik; David, Leonor. "Molecular mechanisms involved in peritoneal carcinomatosis of ovarian cancer". Paper presented in 13th Porto Cancer Meeting, 2015.
  11. Pinto, Rita; Coelho, Ricardo; David, Leonor; Almeida, Raquel. "Impact of CDX2 abrogation on the intestinal phenotype". Paper presented in 13th Porto Cancer Meeting, Porto, 2015.
  12. Garcia, V.; Marques MR; Sousa MO; Carolino, I.; F Santos Silva; Pereira RM; Almeida, Raquel; et al. "Cloning of the bovine MUC1 mucin gene promoter. (abstract p.207)". Paper presented in V Congress of the Portuguese Society of Veterinary Sciences, 2011.
Journal article
  1. D. Pádua; Figueira, Paula; Pombinho, António; Monteiro, Inês; Pereira, Carlos Filipe; Almeida, Raquel; Mesquita, Patrícia. "HMGA1 stimulates cancer stem-like features and sensitivity to monensin in gastric cancer". Experimental Cell Research 442 2 (2024): 114257. http://dx.doi.org/10.1016/j.yexcr.2024.114257.
    10.1016/j.yexcr.2024.114257
  2. Vilarinho, Tomás; Pádua, Diana; Pereira, Bruno; Mesquita, Patrícia; Almeida, Raquel. "MISP Is Overexpressed in Intestinal Metaplasia and Gastric Cancer". Current Oncology 31 5 (2024): 2769-2779. http://dx.doi.org/10.3390/curroncol31050210.
    10.3390/curroncol31050210
  3. Nunes, Mariana; Bartosch, Carla; Abreu, Miguel Henriques; Richardson, Alan; Almeida, Raquel; Ricardo, Sara. "Deciphering the Molecular Mechanisms behind Drug Resistance in Ovarian Cancer to Unlock Efficient Treatment Options". Cells (2024): https://doi.org/10.3390/cells13090786.
    10.3390/cells13090786
  4. Pádua, Diana; Figueira, Paula; Pombinho, António; Monteiro, Inês; Pereira, Carlos Filipe; Almeida, Raquel; Mesquita, Patricia. "Upregulation of HMGA1 confers cancer stem-like features to gastric cancer cells". FEBS Letters (2024):
    Under revision
  5. Pádua, Diana; Figueira, Paula; Pinto, Mariana; Maia, André Filipe; Peixoto, Joana; Lima, Raquel T.; Pombinho, António; et al. "High-Throughput Drug Screening Revealed That Ciclopirox Olamine Can Engender Gastric Cancer Stem-like Cells". Cancers 15 17 (2023): 4406. http://dx.doi.org/10.3390/cancers15174406.
    10.3390/cancers15174406
  6. Pimenta, Joana; Ribeiro, Ricardo; Almeida, Raquel; Costa, Pedro F.; da Silva, Marta A.; Pereira, Bruno. "Organ-on-Chip Approaches for Intestinal 3D In Vitro Modeling". Cellular and Molecular Gastroenterology and Hepatology 13 2 (2022): 351-367. http://dx.doi.org/10.1016/j.jcmgh.2021.08.015.
    Open access • Published • 10.1016/j.jcmgh.2021.08.015
  7. Pádua, Diana; Pinto, Débora Filipa; Figueira, Paula; Pereira, Carlos Filipe; Almeida, Raquel; Mesquita, Patrícia. "HMGA1 Has Predictive Value in Response to Chemotherapy in Gastric Cancer". Current Oncology 29 1 (2021): 56-67. http://dx.doi.org/10.3390/curroncol29010005.
    Open access • Published • 10.3390/curroncol29010005
  8. Pereira, Carla; Park, Ji-Hyeon; Campelos, Sofia; Gullo, Irene; Lemos, Carolina; Solorzano, Leslie; Martins, Diana; et al. "Comparison of East-Asia and West-Europe cohorts explains disparities in survival outcomes and highlights predictive biomarkers of early gastric cancer aggressiveness". International Journal of Cancer 150 5 (2021): 868-880. http://dx.doi.org/10.1002/ijc.33872.
    Published • 10.1002/ijc.33872
  9. Sara Ribeirinho-Soares; Diana Pádua; Ana Luísa Amaral; Elvia Valentini; Daniela Azevedo; Cristiana Marques; Rita Barros; et al. "Prognostic significance of MUC2, CDX2 and SOX2 in stage II colorectal cancer patients". BMC Cancer (2021): https://doi.org/10.1186/s12885-021-08070-6.
    10.1186/s12885-021-08070-6
  10. Amaro, Helena M.; Barros, Rita; Tavares, Tânia; Almeida, Raquel; Pinto, Isabel Sousa; Malcata, Francisco Xavier; Guedes, Ana Catarina. "Gloeothece sp.—Exploiting a New Source of Antioxidant, Anti-Inflammatory, and Antitumor Agents". Marine Drugs 19 11 (2021): 623. http://dx.doi.org/10.3390/md19110623.
    Open access • Published • 10.3390/md19110623
  11. Almeida, Gabriela M; Pereira, Carla; Park, Ji-Hyeon; Lemos, Carolina; Campelos, Sofia; Gullo, Irene; Martins, Diana; et al. "CD44v6 High Membranous Expression Is a Predictive Marker of Therapy Response in Gastric Cancer Patients". Biomedicines 9 9 (2021): 1249. http://dx.doi.org/10.3390/biomedicines9091249.
    Open access • Published • 10.3390/biomedicines9091249
  12. Henriques, Taciane Barbosa; dos Santos, Diandra Zipinotti; dos Santos Guimarães, Isabella; Tessarollo, Nayara Gusmão; Lyra-Junior, Paulo Cilas Morais; Mesquita, Patricia; Pádua, Diana; et al. "Inhibition of CXCR2 plays a pivotal role in re-sensitizing ovarian cancer to cisplatin treatment". Aging 13 10 (2021): 13405-13420. http://dx.doi.org/10.18632/aging.203074.
    Published • 10.18632/aging.203074
  13. Solorzano, Leslie; Pereira, Carla; Martins, Diana; Almeida, Raquel; Carneiro, Fatima; Almeida, Gabriela M.; Oliveira, Carla; Wahlby, Carolina. "Towards Automatic Protein Co-Expression Quantification in Immunohistochemical TMA Slides". IEEE Journal of Biomedical and Health Informatics 25 2 (2021): 393-402. http://dx.doi.org/10.1109/jbhi.2020.3008821.
    10.1109/jbhi.2020.3008821
  14. Pádua, Diana; Figueira, Paula; Ribeiro, Inês; Almeida, Raquel; Mesquita, Patrícia. "The Relevance of Transcription Factors in Gastric and Colorectal Cancer Stem Cells Identification and Eradication". Frontiers in Cell and Developmental Biology 8 (2020): http://dx.doi.org/10.3389/fcell.2020.00442.
    10.3389/fcell.2020.00442
  15. Coelho, Ricardo; Ricardo, Sara; Amaral, Ana Luísa; Huang, Yen-Lin; Nunes, Mariana; Neves, José Pedro; Mendes, Nuno; et al. "Regulation of invasion and peritoneal dissemination of ovarian cancer by mesothelin manipulation". Oncogenesis 9 6 (2020): http://dx.doi.org/10.1038/s41389-020-00246-2.
    10.1038/s41389-020-00246-2
  16. Pereira, Bruno; Amaral, Ana L; Dias, Alexandre; Mendes, Nuno; Muncan, Vanesa; Silva, Ana R; Thibert, Chantal; et al. "MEX3A regulates Lgr5 + stem cell maintenance in the developing intestinal epithelium". EMBO reports 21 4 (2020): http://dx.doi.org/10.15252/embr.201948938.
    Open access • Published • 10.15252/embr.201948938
  17. Lopes, Nair; Bergsland, Christian; Bruun, Jarle; Bjørnslett, Merete; Vieira, André Filipe; Mesquita, Patrícia; Pinto, Rita; et al. "A panel of intestinal differentiation markers (CDX2, GPA33, and LI-cadherin) identifies gastric cancer patients with favourable prognosis". Gastric Cancer (2020): http://dx.doi.org/10.1007/s10120-020-01064-6.
    In press • 10.1007/s10120-020-01064-6
  18. Pádua, Diana; Barros, Rita; Amaral, Ana Luísa; Mesquita, Patrícia; Freire, Ana Filipa; Sousa, Mafalda; Maia, André Filipe; et al. "A SOX2 Reporter System Identifies Gastric Cancer Stem-Like Cells Sensitive to Monensin". Cancers 12 2 (2020): 495. http://dx.doi.org/10.3390/cancers12020495.
    Open access • Published • 10.3390/cancers12020495
  19. Carneiro, Patrícia; Moreira, Ana Margarida; Figueiredo, Joana; Barros, Rita; Oliveira, Patrícia; Fernandes, Maria Sofia; Ferro, Anabela; et al. "S100P is a molecular determinant of E-cadherin function in gastric cancer". Cell Communication and Signaling 17 1 (2019): http://dx.doi.org/10.1186/s12964-019-0465-9.
    10.1186/s12964-019-0465-9
  20. Lopes, Nair; Bergsland, Christian Holst; Bjørnslett, Merete; Pellinen, Teijo; Svindland, Aud; Nesbakken, Arild; Almeida, Raquel; et al. "Digital image analysis of multiplex fluorescence IHC in colorectal cancer recognizes the prognostic value of CDX2 and its negative correlation with SOX2". Laboratory Investigation 100 1 (2019): 120-134. http://dx.doi.org/10.1038/s41374-019-0336-4.
    10.1038/s41374-019-0336-4
  21. Mesquita, Patrícia; Freire, Ana F.; Lopes, Nair; Gomes, Rosa; Azevedo, Daniela; Barros, Rita; Pereira, Bruno; et al. "Expression and Clinical Relevance of SOX9 in Gastric Cancer". Disease Markers 2019 (2019): 1-11. http://dx.doi.org/10.1155/2019/8267021.
    10.1155/2019/8267021
  22. Bruun, Jarle; Sveen, Anita; Barros, Rita; Eide, Peter W.; Eilertsen, Ina; Kolberg, Matthias; Pellinen, Teijo; et al. "Prognostic, predictive, and pharmacogenomic assessments of CDX2 refine stratification of colorectal cancer". Molecular Oncology 12 9 (2018): 1639-1655. http://dx.doi.org/10.1002/1878-0261.12347.
    10.1002/1878-0261.12347
  23. Rolim, I.; Rodrigues, R.V.; Bettencourt, A.; Barros, R.; Camilo, V.; Dias Pereira, A.; Almeida, R.; Chaves, P.. "Mid-Esophagus Columnar Metaplasia: What Is the Biopathogenic Pathway?". International Journal of Surgical Pathology 25 3 (2017): 262-265. http://www.scopus.com/inward/record.url?eid=2-s2.0-85018354529&partnerID=MN8TOARS.
    10.1177/1066896916672332
  24. Pinto, R.; Hansen, L.; Hintze, J.; Almeida, R.; Larsen, S.; Coskun, M.; Davidsen, J.; et al. "Precise integration of inducible transcriptional elements (PrIITE) enables absolute control of gene expression". Nucleic Acids Research 45 13 (2017): http://www.scopus.com/inward/record.url?eid=2-s2.0-85026430499&partnerID=MN8TOARS.
    10.1093/nar/gkx371
  25. Tsai, M.-H.; Lin, X.; Shumilov, A.; Bernhardt, K.; Feederle, R.; Poirey, R.; Kopp-Schneider, A.; et al. "The biological properties of different Epstein-Barr virus strains explain their association with various types of cancers". Oncotarget 8 6 (2017): 10238-10254. http://www.scopus.com/inward/record.url?eid=2-s2.0-85012012695&partnerID=MN8TOARS.
    10.18632/oncotarget.14380
  26. Pereira, B.; Billaud, M.; Almeida, R.. "RNA-Binding Proteins in Cancer: Old Players and New Actors". Trends in Cancer 3 7 (2017): 506-528. http://www.scopus.com/inward/record.url?eid=2-s2.0-85020932454&partnerID=MN8TOARS.
    10.1016/j.trecan.2017.05.003
  27. Oliveira, P.; Carvalho, J.; Rocha, S.; Azevedo, M.; Reis, I.; Camilo, V.; Sousa, B.; et al. "Dies1/VISTA expression loss is a recurrent event in gastric cancer due to epigenetic regulation". Scientific Reports 6 (2016): http://www.scopus.com/inward/record.url?eid=2-s2.0-84990946691&partnerID=MN8TOARS.
    10.1038/srep34860
  28. Sousa, A.M.; Rei, M.; Freitas, R.; Ricardo, S.; Caffrey, T.; David, L.; Almeida, R.; Hollingsworth, M.A.; Santos-Silva, F.. "Effect of MUC1/ß-catenin interaction on the tumorigenic capacity of pancreatic CD133+ cells". Oncology Letters 12 3 (2016): 1811-1817. http://www.scopus.com/inward/record.url?eid=2-s2.0-84979697127&partnerID=MN8TOARS.
    10.3892/ol.2016.4888
  29. Sousa, A.M.; Grandgenett, P.M.; David, L.; Almeida, R.; Hollingsworth, M.A.; Santos-Silva, F.. "Reflections on MUC1 glycoprotein: the hidden potential of isoforms in carcinogenesis". APMIS 124 11 (2016): 913-924. http://www.scopus.com/inward/record.url?eid=2-s2.0-84982306248&partnerID=MN8TOARS.
    10.1111/apm.12587
  30. Sadio, A.; Amaral, A.L.; Nunes, R.; Ricardo, S.; Sarmento, B.; Almeida, R.; Tsukamoto, H.; das Neves, J.. "A mouse intra-intestinal infusion model and its application to the study of nanoparticle distribution". Frontiers in Physiology 7 NOV (2016): http://www.scopus.com/inward/record.url?eid=2-s2.0-85006371437&partnerID=MN8TOARS.
    10.3389/fphys.2016.00579
  31. Rita Barros; Daniela Pereira; Catarina Callé; Vânia Camilo; Ana Isabel Cunha; Leonor David; Raquel Almeida; António Dias-Pereira; Paula Chaves. "Dynamics of SOX2 and CDX2 Expression in Barrett’s Mucosa". Disease Markers 2016 (2016): 1-7. http://dx.doi.org/10.1155/2016/1532791.
    10.1155/2016/1532791
  32. Pinto, Rita; Barros, Rita; Pereira-Castro, Isabel; Mesquita, Patricia; da Costa, Luis T.; Bennett, Eric P.; Almeida, Raquel; David, Leonor. "CDX2 homeoprotein is involved in the regulation of ST6GalNAc-I gene in intestinal metaplasia". Laboratory Investigation 95 7 (2015): 718-727. http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=CCC&KeyUT=CCC:000357060000002&KeyUID=CCC:000357060000002.
  33. Ricardo, Sara; Marcos-Silva, Lara; Pereira, Daniela; Pinto, Rita; Almeida, Raquel; Soderberg, Ola; Mandel, Ulla; et al. "Detection of glyco-mucin profiles improves specificity of MUC16 and MUC1 biomarkers in ovarian serous tumours". Molecular Oncology 9 2 (2015): 503-512. http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000349582800014&KeyUID=WOS:000349582800014.
    10.1016/j.molonc.2014.10.005
  34. Camilo, Vania; Garrido, Monica; Valente, Pedro; Ricardo, Sara; Amaral, Ana Luisa; Barros, Rita; Chaves, Paula; et al. "Differentiation reprogramming in gastric intestinal metaplasia and dysplasia: role of SOX2 and CDX2". Histopathology 66 3 (2015): 343-350. http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000348727200003&KeyUID=WOS:000348727200003.
    10.1111/his.12544
  35. Pinto, R.; Barros, R.; Pereira-Castro, I.; Mesquita, P.; Da Costa, L.T.; Bennett, E.P.; Almeida, R.; David, L.. "CDX2 homeoprotein is involved in the regulation of ST6GalNAc-I gene in intestinal metaplasia". Laboratory Investigation 95 7 (2015): 718-727. http://www.scopus.com/inward/record.url?eid=2-s2.0-84933060097&partnerID=MN8TOARS.
    10.1038/labinvest.2015.52
  36. Camilo, Vania; Barros, Rita; Celestino, Ricardo; Castro, Patrcia; Vieira, Joana; Teixeira, Manuel R.; Carneiro, Fatima; et al. "Immunohistochemical molecular phenotypes of gastric cancer based on SOX2 and CDX2 predict patient outcome". Bmc Cancer 14 (2014):
    10.1186/1471-2407-14-753
  37. Sadio, Ana; Gustafsson, Jenny K.; Pereira, Bruno; Gomes, Carla Pereira; Hansson, Gunnar C.; David, Leonor; Pego, Ana Paula; Almeida, Raquel. "Modified-Chitosan/siRNA Nanoparticles Downregulate Cellular CDX2 Expression and Cross the Gastric Mucus Barrier". Plos One 9 6 (2014):
    10.1371/journal.pone.0099449
  38. Pereira, B.; Sousa, S.; Barros, R.; Carreto, L.; Oliveira, P.; Oliveira, C.; Chartier, N.T.; et al. "CDX2 regulation by the RNA-binding protein MEX3A: Impact on intestinal differentiation and stemness". Nucleic Acids Research 41 7 (2013): 3986-3999. http://www.scopus.com/inward/record.url?eid=2-s2.0-84876542486&partnerID=MN8TOARS.
    10.1093/nar/gkt087
  39. Pereira, Bruno; Le Borgne, Mailys; Chartier, Nicolas T.; Billaud, Marc; Almeida, Raquel. "MEX-3 proteins: recent insights on novel post-trascriptional regulators". Trends in Biochemical Sciences 38 10 (2013): 477-479.
    10.1016/j.tibs.2013.08.004
  40. Peleteiro, B.; Lunet, N.; Wen, X.; Afonso, L.P.; Mendes, N.; Barros, R.; Carneiro, F.; Almeida, R.; Barros, H.. "Association between environmental factors and CDX2 expression in gastric cancer patients". European Journal of Cancer Prevention 21 5 (2012): 423-431. http://www.scopus.com/inward/record.url?eid=2-s2.0-84864358456&partnerID=MN8TOARS.
    10.1097/CEJ.0b013e32834ef1aa
  41. Pinto, R.; Carvalho, A.S.; Conze, T.; Magalhães, A.; Picco, G.; Burchell, J.M.; Taylor-Papadimitriou, J.; et al. "Identification of new cancer biomarkers based on aberrant mucin glycoforms by in situ proximity ligation". Journal of Cellular and Molecular Medicine 16 7 (2012): 1474-1484. http://www.scopus.com/inward/record.url?eid=2-s2.0-84863091545&partnerID=MN8TOARS.
    10.1111/j.1582-4934.2011.01436.x
  42. Camilo, V.; Barros, R.; Sousa, S.; Magalhães, A.M.; Lopes, T.; Santos, A.M.; Pereira, T.; et al. "Helicobacter pylori and the BMP pathway regulate CDX2 and SOX2 expression in gastric cells". Carcinogenesis 33 10 (2012): 1985-1992. http://www.scopus.com/inward/record.url?eid=2-s2.0-84865579254&partnerID=MN8TOARS.
    10.1093/carcin/bgs233
  43. Barros, R.; Freund, J.-N.; David, L.; Almeida, R.. "Gastric intestinal metaplasia revisited: Function and regulation of CDX2". Trends in Molecular Medicine 18 9 (2012): 555-563. http://www.scopus.com/inward/record.url?eid=2-s2.0-84865606611&partnerID=MN8TOARS.
    10.1016/j.molmed.2012.07.006
  44. Peleteiro, B.; Barros, R.; Carrilho, C.; Artiaga, J.; Cunha, L.; Modcoicar, P.; Ferreira, R.; et al. "Determinants of gastric CDX2 expression: A study in Mozambique". European Journal of Cancer Prevention 21 6 (2012): 532-540. http://www.scopus.com/inward/record.url?eid=2-s2.0-84866981560&partnerID=MN8TOARS.
    10.1097/CEJ.0b013e3283523480
  45. Barros, R.; Da Costa, L.T.; Pinto-de-Sousa, J.; Duluc, I.; Freund, J.-N.; David, L.; Almeida, R.. "CDX2 autoregulation in human intestinal metaplasia of the stomach: Impact on the stability of the phenotype". Gut 60 3 (2011): 290-298. http://www.scopus.com/inward/record.url?eid=2-s2.0-79851514659&partnerID=MN8TOARS.
    10.1136/gut.2010.222323
  46. Barros, R.; Camilo, V.; Pereira, B.; Freund, J.-N.; David, L.; Almeida, R.. "Pathophysiology of intestinal metaplasia of the stomach: Emphasis on CDX2 regulation". Biochemical Society Transactions 38 2 (2010): 358-363. http://www.scopus.com/inward/record.url?eid=2-s2.0-77953279584&partnerID=MN8TOARS.
    10.1042/BST0380358
  47. Silva, L.M.; Carvalho, A.S.; Guillon, P.; Seixas, S.; Azevedo, M.; Almeida, R.; Ruvoën-Clouet, N.; et al. "Infection-associated FUT2 (Fucosyltransferase 2) genetic variation and impact on functionality assessed by in vivo studies". Glycoconjugate Journal 27 1 (2010): 61-68. http://www.scopus.com/inward/record.url?eid=2-s2.0-77749280085&partnerID=MN8TOARS.
    10.1007/s10719-009-9255-8
  48. Carvalho, A.S.; Harduin-Lepers, A.; Magalhães, A.; Machado, E.; Mendes, N.; Costa, L.T.; Matthiesen, R.; et al. "Differential expression of a-2,3-sialyltransferases and a-1,3/4-fucosyltransferases regulates the levels of sialyl Lewis a and sialyl Lewis x in gastrointestinal carcinoma cells". International Journal of Biochemistry and Cell Biology 42 1 (2010): 80-89. http://www.scopus.com/inward/record.url?eid=2-s2.0-70649087034&partnerID=MN8TOARS.
    10.1016/j.biocel.2009.09.010
  49. Botelho, M.C.; Soares, R.; Vale, N.; Ribeiro, R.; Camilo, V.; Almeida, R.; Medeiros, R.; et al. "Schistosoma haematobium: Identification of new estrogenic molecules with estradiol antagonistic activity and ability to inactivate estrogen receptor in mammalian cells". Experimental Parasitology 126 4 (2010): 526-535. http://www.scopus.com/inward/record.url?eid=2-s2.0-79960934913&partnerID=MN8TOARS.
    10.1016/j.exppara.2010.06.012
  50. Barros, R.; Peleteiro, B.; Almeida, R.; Figueiredo, C.; Barros, H.; David, L.; Lunet, N.. "Relevance of high virulence Helicobacter pylori strains and futility of CDX2 expression for predicting intestinal metaplasia after eradication of infection". Scandinavian Journal of Gastroenterology 45 7-8 (2010): 828-834. http://www.scopus.com/inward/record.url?eid=2-s2.0-77955694652&partnerID=MN8TOARS.
    10.3109/00365521003770269
  51. Conze, T.; Carvalho, A.S.; Landegren, U.; Almeida, R.; Reis, C.A.; David, L.; Söderberg, O.. "MUC2 mucin is a major carrier of the cancer-associated sialyl-Tn antigen in intestinal metaplasia and gastric carcinomas". Glycobiology 20 2 (2009): 199-206. http://www.scopus.com/inward/record.url?eid=2-s2.0-77649216263&partnerID=MN8TOARS.
    10.1093/glycob/cwp161
  52. Barros, R.; Mendes, N.; Howe, J.R.; Reis, C.A.; De Bolos, C.; Carneiro, F.; David, L.; Almeida, R.. "Juvenile polyps have gastric differentiation with MUC5AC expression and downregulation of CDX2 and SMAD4". Histochemistry and Cell Biology 131 6 (2009): 765-772. http://www.scopus.com/inward/record.url?eid=2-s2.0-67349211762&partnerID=MN8TOARS.
    10.1007/s00418-009-0579-z
  53. Gomes, J.; Marcos, N.T.; Berois, N.; Osinaga, E.; Magalhães, A.; Pinto-de-Sousa, J.; Almeida, R.; Gärtner, F.; Reis, C.A.. "Expression of UDP-N-acetyl-D-galactosamine: Polypeptide N-acetylgalactosaminyltransferase-6 in gastric mucosa, intestinal metaplasia, and gastric carcinoma". Journal of Histochemistry and Cytochemistry 57 1 (2009): 79-86. http://www.scopus.com/inward/record.url?eid=2-s2.0-58149199902&partnerID=MN8TOARS.
    10.1369/jhc.2008.952283
  54. Peleteiro, B.; Carrilho, C.; Modcoicar, P.; Cunha, L.; Ismail, M.; Guisseve, A.; Lorenzoni, C.; et al. "Chronic atrophic gastritis, intestinal metaplasia, helicobacter pylori virulence, IL1RN polymorphisms, and smoking in dyspeptic patients from Mozambique and Portugal". Helicobacter 14 4 (2009): 306-308. http://www.scopus.com/inward/record.url?eid=2-s2.0-68349100219&partnerID=MN8TOARS.
    10.1111/j.1523-5378.2009.00687.x
  55. Carrilho, C.; Modcoicar, P.; Cunha, L.; Ismail, M.; Guisseve, A.; Lorenzoni, C.; Fernandes, F.; et al. "Prevalence of Helicobacter pylori infection, chronic gastritis, and intestinal metaplasia in Mozambican dyspeptic patients". Virchows Archiv 454 2 (2009): 153-160. http://www.scopus.com/inward/record.url?eid=2-s2.0-59849118857&partnerID=MN8TOARS.
    10.1007/s00428-008-0713-7
  56. Pereira, B.; Oliveira, C.; David, L.; Almeida, R.. "CDX2 promoter methylation is not associated with mRNA expression". International Journal of Cancer 125 7 (2009): 1739-1742. http://www.scopus.com/inward/record.url?eid=2-s2.0-68549086983&partnerID=MN8TOARS.
    10.1002/ijc.24544
  57. Barros, R.; Marcos, N.; Reis, C.A.; De Luca, A.; David, L.; Almeida, R.. "CDX2 expression is induced by Helicobacter pylori in AGS cells". Scandinavian Journal of Gastroenterology 44 1 (2009): 124-125. http://www.scopus.com/inward/record.url?eid=2-s2.0-58149099117&partnerID=MN8TOARS.
    10.1080/00365520802530846
  58. Barros, R.; Pereira, B.; Duluc, I.; Azevedo, M.; Mendes, N.; Camilo, V.; Jacobs, R.J.; et al. "Key elements of the BMP/SMAD pathway co-localize with CDX2 in intestinal metaplasia and regulate CDX2 expression in human gastric cell lines". Journal of Pathology 215 4 (2008): 411-420. http://www.scopus.com/inward/record.url?eid=2-s2.0-49449092484&partnerID=MN8TOARS.
    10.1002/path.2369
  59. Serpa, J.; Mesquita, P.; Mendes, N.; Oliveira, C.; Almeida, R.; Santos-Silva, F.; Reis, C.A.; LePendu, J.; David, L.. "Expression of Lea in gastric cancer cell lines depends on FUT3 expression regulated by promoter methylation". Cancer Letters 242 2 (2006): 191-197. http://www.scopus.com/inward/record.url?eid=2-s2.0-33749246714&partnerID=MN8TOARS.
    10.1016/j.canlet.2005.11.009
  60. Mesquita, P.; Almeida, R.; Lunet, N.; Reis, C.A.; Silva, L.F.S.; Serpa, J.; Van Seuningen, I.; Barros, H.; David, L.. "Metaplasia - A transdifferentiation process that facilitates cancer development: The model of gastric intestinal metaplasia". Critical Reviews in Oncogenesis 12 1-2 (2006): 3-26. http://www.scopus.com/inward/record.url?eid=2-s2.0-33749344533&partnerID=MN8TOARS.
  61. Santos-Silva, F.; Fonseca, A.; Caffrey, T.; Carvalho, F.; Mesquita, P.; Reis, C.; Almeida, R.; David, L.; Hollingsworth, M.A.. "Thomsen-Friedenreich antigen expression in gastric carcinomas is associated with MUC1 mucin VNTR polymorphism". Glycobiology 15 5 (2005): 511-517. http://www.scopus.com/inward/record.url?eid=2-s2.0-23944447993&partnerID=MN8TOARS.
    10.1093/glycob/cwi027
  62. Almeida, R.; Almeida, J.; Shoshkes, M.; Mendes, N.; Mesquita, P.; Silva, E.; Van Seuningen, I.; et al. "OCT-1 is over-expressed in intestinal metaplasia and intestinal gastric carcinomas and binds to, but does not transactivate, CDX2 in gastric cells". Journal of Pathology 207 4 (2005): 396-401. http://www.scopus.com/inward/record.url?eid=2-s2.0-29744467037&partnerID=MN8TOARS.
    10.1002/path.1861
  63. Mesquita, P.; Almeida, R.; Van Seuningen, I.; David, L.. "Coordinated expression of MUC2 and CDX-2 in mucinous carcinomas of the lung can be explained by the role of CDX-2 as transcriptional regulator of MUC2 [3]". American Journal of Surgical Pathology 28 9 (2004): 1254-1255. http://www.scopus.com/inward/record.url?eid=2-s2.0-4344561195&partnerID=MN8TOARS.
    10.1097/01.pas.0000135517.50095.7f
  64. Serpa, J.; Mendes, N.; Reis, C.A.; Santos Silva, L.F.; Almeida, R.; Le Pendu, J.; David, L.. "Two new FUT2 (fucosyltransferase 2 gene) missense polymorphisms, 739G ¿ A and 839T ¿ C, are partly responsible for non-secretor status in a Caucasian population from Northern Portugal". Biochemical Journal 383 3 (2004): 469-474. http://www.scopus.com/inward/record.url?eid=2-s2.0-9144251105&partnerID=MN8TOARS.
    10.1042/BJ20040803
  65. Marcos, N.T.; Pinho, S.; Grandela, C.; Cruz, A.; Samyn-Petit, B.; Harduin-Lepers, A.; Almeida, R.; et al. "Role of the human ST6GalNAc-I and ST6GalNAc-II in the synthesis of the cancer-associated Sialyl-Tn antigen". Cancer Research 64 19 (2004): 7050-7057. http://www.scopus.com/inward/record.url?eid=2-s2.0-4944265751&partnerID=MN8TOARS.
    10.1158/0008-5472.CAN-04-1921
  66. Mesquita, P.; Jonckheere, N.; Almeida, R.; Ducourouble, M.-P.; Serpa, J.; Silva, E.; Pigny, P.; et al. "Human MUC2 Mucin Gene Is Transcriptionally Regulated by Cdx Homeodomain Proteins in Gastrointestinal Carcinoma Cell Lines". Journal of Biological Chemistry 278 51 (2003): 51549-51556. http://www.scopus.com/inward/record.url?eid=2-s2.0-9144240744&partnerID=MN8TOARS.
    10.1074/jbc.M309019200
  67. Almeida, R.; Silva, E.; Santos-Silva, F.; Silberg, D.G.; Wang, J.; De Bolós, C.; David, L.. "Expression of intestine-specific transcription factors, CDX1 and CDX2, in intestinal metaplasia and gastric carcinomas". Journal of Pathology 199 1 (2003): 36-40. http://www.scopus.com/inward/record.url?eid=2-s2.0-0037221727&partnerID=MN8TOARS.
    10.1002/path.1246
  68. Mesquita, P.; Peixoto, A.J.; Seruca, R.; Hanski, C.; Almeida, R.; Silva, F.; Reis, C.; David, L.. "Role of site-specific promoter hypomethylation in aberrant MUC2 mucin expression in mucinous gastric carcinomas". Cancer Letters 189 2 (2003): 129-136. http://www.scopus.com/inward/record.url?eid=2-s2.0-0037469101&partnerID=MN8TOARS.
    10.1016/S0304-3835(02)00549-9
  69. Silva, F.; Carvalho, F.; Peixoto, A.; Teixeira, A.; Almeida, R.; Reis, C.; Bravo, L.E.; et al. "MUC1 polymorphism confers increased risk for intestinal metaplasia in a Colombian population with chronic gastritis". European Journal of Human Genetics 11 5 (2003): 380-384. http://www.scopus.com/inward/record.url?eid=2-s2.0-0038412817&partnerID=MN8TOARS.
    10.1038/sj.ejhg.5200978
  70. Serpa, J.; Almeida, R.; Oliveira, C.; Silva, F.S.; Silva, E.; Reis, C.; Le Pendu, J.; et al. "Lewis enzyme (a1-3/4 fucosyltransferase) polymorphisms do not explain the Lewis phenotype in the gastric mucosa of a Portuguese population". Journal of Human Genetics 48 4 (2003): 183-189. http://www.scopus.com/inward/record.url?eid=2-s2.0-0037908695&partnerID=MN8TOARS.
    10.1007/s10038-003-0007-5
  71. Marcos, N.T.; Cruz, A.; Silva, F.; Almeida, R.; David, L.; Mandel, U.; Clausen, H.; Von Mensdorff-Pouilly, S.; Reis, C.A.. "Polypeptide GalNAc-transferases, ST6GalNAc-transferase I, and ST3Gal-transferase I expression in gastric carcinoma cell lines". Journal of Histochemistry and Cytochemistry 51 6 (2003): 761-771. http://www.scopus.com/inward/record.url?eid=2-s2.0-0037674996&partnerID=MN8TOARS.
  72. Pinto-de-Sousa, J.; David, L.; Almeida, R.; Leitão, D.; Preto, J.R.; Seixas, M.; Pimenta, A.. "c-erb B-2 expression is associated with tumor location and venous invasion and influences survival of patients with gastric carcinoma". International Journal of Surgical Pathology 10 4 (2002): 247-256. http://www.scopus.com/inward/record.url?eid=2-s2.0-0036817076&partnerID=MN8TOARS.
  73. Silva, F.; Carvalho, F.; Peixoto, A.; Seixas, M.; Almeida, R.; Carneiro, F.; Mesquita, P.; et al. "MUC1 gene polymorphism in the gastric carcinogenesis pathway". European Journal of Human Genetics 9 7 (2001): 548-552. http://www.scopus.com/inward/record.url?eid=2-s2.0-17844386040&partnerID=MN8TOARS.
    10.1038/sj.ejhg.5200677
  74. Amado, M.; Almeida, R.; Schwientek, T.; Clausen, H.. "Identification and characterization of large galactosyltransferase gene families: Galactosyltransferases for all functions". Biochimica et Biophysica Acta - General Subjects 1473 1 (1999): 35-53. http://www.scopus.com/inward/record.url?eid=2-s2.0-0032759101&partnerID=MN8TOARS.
    10.1016/S0304-4165(99)00168-3
  75. Almeida, R.; Levery, S.B.; Mandel, U.; Kresse, H.; Schwientek, T.; Bennett, E.P.; Clausen, H.. "Cloning and expression of a proteoglycan UDP-galactose:ß-xylose ß1,4- galactosyltransferase I. A seventh member of the human ß4- galactosyltransferase gene family". Journal of Biological Chemistry 274 37 (1999): 26165-26171. http://www.scopus.com/inward/record.url?eid=2-s2.0-0033543696&partnerID=MN8TOARS.
    10.1074/jbc.274.37.26165
  76. Almeida, R.; Amado, M.; David, L.; Levery, S.B.; Homes, E.H.; Merkx, G.; Van Kessel, A.G.; et al. "Erratum: A family of human ß4-galactosyltransferases. Cloning and expression of two novel UDP-galactose:ß-N-acetylglucosamine ß1,4- galactosyltransferases, ß4Gal-T2 and ß4Gal-T3 (Journal of Biological Chemistry (1997) 272 (31979-31991))". Journal of Biological Chemistry 273 29 (1998): http://www.scopus.com/inward/record.url?eid=2-s2.0-0032540889&partnerID=MN8TOARS.
  77. Ujita, M.; McAuliffe, J.; Schwientek, T.; Almeida, R.; Hindsgaul, O.; Clausen, H.; Fukuda, M.. "Synthesis of poly-N-acetyllactosamine in core 2 branched O-glycans". Journal of Biological Chemistry 273 52 (1998): 34843-34849. http://www.scopus.com/inward/record.url?eid=2-s2.0-0032567431&partnerID=MN8TOARS.
    10.1074/jbc.273.52.34843
  78. Schwientek, T.; Almeida, R.; Levery, S.B.; Holmes, E.H.; Bennett, E.; Clausen, H.. "Cloning of a novel member of the UDP-galactose:ß-N-acetylglucosamine ß1,4-galactosyltransferase family, ß4Gal-T4, involved in glycosphingolipid biosynthesis". Journal of Biological Chemistry 273 45 (1998): 29331-29340. http://www.scopus.com/inward/record.url?eid=2-s2.0-0032491511&partnerID=MN8TOARS.
    10.1074/jbc.273.45.29331
  79. Amado, M.; Almeida, R.; Carneiro, F.; Levery, S.B.; Holmes, E.H.; Nomoto, M.; Hollingsworth, M.A.; et al. "A family of human ß3-galactosyltransferases: Characterization of four members of a UDP-galactose:ß-N-acetyl-glucosamine/ß-N-acetyl-galactosamine ß-1,3-galactosyltransferase family". Journal of Biological Chemistry 273 21 (1998): 12770-12778. http://www.scopus.com/inward/record.url?eid=2-s2.0-0038920413&partnerID=MN8TOARS.
    10.1074/jbc.273.21.12770
  80. Almeida, R.; Amado, M.; David, L.; Levery, S.B.; Holmes, E.H.; Merkx, G.; Van Kessel, A.G.; et al. "A family of human ß4-galactosyltransferases. Cloning and expression of two novel UDP-galactose:ß-N-acetylglucosamine ß1,4-galactosyltransferases, ß4Gal-T2 and ß4Gal-T3". Journal of Biological Chemistry 272 51 (1997): 31979-31991. http://www.scopus.com/inward/record.url?eid=2-s2.0-0344706380&partnerID=MN8TOARS.
    10.1074/jbc.272.51.31979
Preprint
  1. Silva, Ana R.; Coelho, Alexandre; Machado, Vanessa; Russel, Morgana; Mexieiro, Dalila; Amaral, Ana L.; Cavadas, Bruno; et al. "Intestinal stem cell marker MEX3A regulates PPARgamma expression with functional impact in colorectal carcinogenesis". 2025. https://doi.org/10.1101/2025.01.13.632758.
    10.1101/2025.01.13.632758

Other

Other output
  1. CD44v6 expression is a novel predictive marker of therapy response and poor prognosis in gastric cancer patients. 2018. Carla Pereira; Daniel Ferreira; Carolina Lemos; Diana Martins; Nuno Mendes; Daniela Almeida; Pedro Granja; et al. https://doi.org/10.1101/468934.
    10.1101/468934
Activities

Oral presentation

Presentation title Event name
Host (Event location)
2020/05/05 A SOX2 reporter system identifies gastric cancer stem-like cells sensitive to monensin 27th Porto Cancer Meeting
Ipatimup (Porto, Portugal)
2019/04/06 Caracterização de células estaminais de cancro gástrico Ciclo de conferências "Biologia ao Fim da Tarde"
FCUP (Porto, Portugal)
2017/07/01 Cancer Stem Cells 35th Youth Science Meeting
(Porto, Portugal)
2017/06/01 Characterization of a novel intestinal stem cell marker One day symposium with Patrick Tan: Knowns and Unknowns in Gastric Cancer and Other Tumours of the Digestive System
(Porto, Portugal)
2017/02/02 Stemness and differentiation markers in development and cancer Group Leader Seminars
i3S (porto, Portugal)
2017/02/01 Stemness and differentiation markers in development and cancer
UC-Biotech, Cantanhede
2014/06/02 Tissue regeneration with aberrant differentiation - stem cell reprogramming
Instituto Português de Oncologia (Lisboa, Portugal)
2014/04/01 Tissue regeneration with aberrant differentiation. Faculty of Pharmacy, University of Porto
Faculty of Pharmacy, University of Porto (Porto, Portugal)
2014/03/01 Intestinal metaplasia of the stomach: a model of tissue regeneration with aberrant differentiation.
INSERM/UJF U823 (Grenoble, France)
2012/07/06 CDX2 regulation in gastric intestinal metaplasia. Instituto Português de Oncologia
Instituto Português de Oncologia (Porto, Portugal)
2012/06/06 CDX2 and intestinal metaplasia
Instituto Português de Oncologia (Lisboa, Portugal)
2012/04/06 The Bone Morphogenetic Protein (BMP) pathway in gastric intestinal metaplasia International Meeting of the Portuguese Society for Stem Cells & Cell Therapies
(Porto, Portugal)
2012/04/05 Regulation of transdifferentiation in cancer development SINAL 2012 - 6th National Meeting on Cell Signaling
ICVS – ECSaúde (Braga, Portugal)

Supervision

Thesis Title
Role 		Degree Subject (Type)
Institution / Organization
2023/01/01 - 2026/12/31 Study of RNA-binding protein networks in colorectal cancer cells
Co-supervisor of Alexandre Coelho
Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal
2022/01/01 - 2025/12/31 RBPlasticity: RNA-binding proteins role in normal and malignant intestinal stem cell reprogramming
Co-supervisor of Ana Rita Silva
 Biomedicine (PhD)
Universidade do Porto Faculdade de Medicina, Portugal
2020/01/01 - 2023/12/31 Unveiling the molecular networks behind gastric cancer stem cells phenotype: the path for therapy success
Supervisor
 Ciências Biomédicas (PhD)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2020/01/01 - 2023/12/31 Epitranscriptomics in gastric cancer: characterization of YTHDF3 function
Supervisor
 Ciências Biomédicas (PhD)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2022/09/01 - 2023/12/11 Exploring the relevance of marine animal venoms to treat cancer
Supervisor of Pedro Silva
Universidade do Porto, Portugal
2019/09/01 - 2020/07/31 A novel post-transcriptional regulatory network controlling intestinal stem cells fate
Co-supervisor
 Medicina e Oncologia Molecular (Master)
Universidade do Porto Faculdade de Medicina, Portugal
2019/09/01 - 2020/07/31 Isolation and characterization of cancer stem cells (CSCs) from colorectal cancer –transcription factors involved in their reprogramming.
Co-supervisor
 Oncologia (Master)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2019/09/01 - 2020/07/31 The epitranscriptome in gastric cancer: the role of m6A modification
Supervisor
 Biologia Celular e Molecular (Master)
Universidade do Porto Faculdade de Ciências, Portugal
2019/09/01 - 2020/07/31 UNVEILING THE TRANSCRIPTIONAL NETWORK BEHIND GASTRIC CANCER STEM CELLS PHENOTYPE
Supervisor
 Medicina e Oncologia Molecular (Master)
Universidade do Porto Faculdade de Medicina, Portugal
2014/01/01 - 2020/03/31 Molecular mechanisms of mucin MUC16 - Mesothelin interaction in ovarian cancer dissemination
Co-supervisor
 Biomedicina (PhD)
Universidade do Porto Faculdade de Medicina, Portugal
2018/09/01 - 2019/07/31 Role of the RNA-binding protein MEX3A in intestinal carcinogenesis
Co-supervisor
 Medicina e Oncologia Molecular (Master)
Universidade do Porto Faculdade de Medicina, Portugal
2018/09/01 - 2019/07/31 Identificação de novos biomarcadores de prognóstico em cancro colorectal estadio II- papel da epitranscriptómica
Supervisor
 Bioquímica (Degree)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2018/09/01 - 2019/06/30 Identification of new biomarkers in gastric cancer- the role of epitranscriptomics
Supervisor
 Biologia (Degree)
Universidade do Porto Faculdade de Ciências, Portugal
2018/09/01 - 2019/06/30 Avaliação da expressão da RhoGTPase -AHRGAP18- e da sua relevância clinica no cancro gástrico
Co-supervisor
 Biologia (Degree)
Universidade do Porto Faculdade de Ciências, Portugal
2018/11/01 - 2019/05/31 Estudo da modulação da expressão de NAC1 e BCL6 na aquisição do fenótipo quimiorresistente aos derivados de platina e aos taxanos por células de câncer de ovário: papel do microambiente tumoral via expressão de CXCL2 e IL8
Co-supervisor
Universidade Federal do Espírito Santo, Brazil
2016/01/01 - 2018/12/31 Clinical biomarkers of stemness and immunity in the context of genetic heterogeneity in colorectal cancer. Post-Doc, Scientia Fellow
Co-supervisor
2015/01/01 - 2018/12/31 Integrating Metabolic and Polarity Alterations in Cancer by post-transcriptional modulation of the LKB1-AMPK-mTOR axis (IMPACTOR): the role of the RNA-binding protein MEX3A Post-Doc (SFRH/BPD/109794/2015)
Supervisor
2015/01 - 2018/12/31 Genetic profile and clonal evolution of stomach premalignant conditions: detecting the point of no return in gastric carcinogenesis. Post-Doc (SFRH/BPD/99442/2014)
Co-supervisor
2017/09/01 - 2018/11/30 New molecular prognostic and predictive biomarkers in stage II colorectal cancer
Supervisor
 Bioquímica em Saúde (Master)
Instituto Politécnico do Porto Escola Superior de Saúde, Portugal
2017/09/01 - 2018/06/30 Assessing the impact of SOX2 expression in gastric cancer cells using Comet assay
Supervisor
 Biologia (Degree)
Universidade do Porto Faculdade de Ciências, Portugal
2017/09/01 - 2018/06/30 Study of post-transcriptional regulation of metabolic reprogramming of cancer cells
Co-supervisor
 Biologia (Degree)
Universidade do Porto Faculdade de Ciências, Portugal
2010/01/01 - 2017/12/31 Mouse models of intestinal metaplasia: exploring pathways from the TGF-beta superfamily. Post-Doc (SFRH/BPD/68276/2010)
Supervisor
2011/07/01 - 2017/12/21 Reverting Gastric Intestinal Metaplasia using siRNAs directed to CDX2
Supervisor
 Medicina e Oncologia Molecular (PhD)
Universidade do Porto Faculdade de Medicina, Portugal
2016/09/01 - 2017/11/30 Identifying a new intestinal stem cell marker with implications in development and cancer
Supervisor
 Genética Molecular e Biomedicina (Master)
Universidade Nova de Lisboa, Portugal
2016/09/01 - 2017/10/31 Isolation and characterization of gastric cancer stem cells based on SOX2/OCT4 activity
Supervisor
 Bioquímica (Master)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2016/09/01 - 2017/06/30 Gastric organoid production: study of the impact of mutation in the MEX3A gene
Supervisor
 Biologia (Degree)
Universidade do Porto Faculdade de Ciências, Portugal
2015/09/01 - 2016/11/30 Reprogramação da diferenciação por miRNAs dependentes do CDX2
Supervisor
 Biotecnologia para as Ciências da Saúde (Master)
Universidade de Trás-os-Montes e Alto Douro, Portugal
2015/09/01 - 2016/07/31 SOX2 as a prognostic marker of treatment response in gastric cancer patients
Co-supervisor
 Medicina
Universidade do Porto Faculdade de Medicina, Portugal
2011/01/01 - 2015/04/30 Cancer-associated sialyl-Tn carbohydrate antigen - regulation of its expression by CDX2 homeoprotein and contribution of mucin protein carriers for cancer progression
Co-supervisor
 Biomedicina (PhD)
Universidade do Porto Faculdade de Medicina, Portugal
2010/01/01 - 2014/11/30 Sox2 modulation in the establishment of CDX2-dependent intestinal metaplasia of the stomach
Supervisor
 Biomedicina (PhD)
Universidade do Porto Faculdade de Medicina, Portugal
2013/09/01 - 2014/07/31 SOX2 and CDX2 in gastric intestinal metaplasia and dysplasia: impact on differentiation
Supervisor
 Medicina (Master)
Universidade do Porto Faculdade de Medicina, Portugal
2013/09/01 - 2014/07/01 Bone Morphogenetic proteins in the gastrointestinal tract
Supervisor
 Medicina (Master)
Universidade do Porto Faculdade de Medicina, Portugal
2012/09/01 - 2013/10/30 A model of BMP pathway overexpression in the gastrointestinal tract – an in vivo approach
Supervisor
 Oncologia (Master)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2009/01/01 - 2013/04/30 Regulation of CDX2 expression by cellular interactions
Supervisor
 Biomedicina (PhD)
Universidade do Porto Faculdade de Medicina, Portugal
2007/01/01 - 2010/12/31 Identification of signaling pathways involved in CDX2 regulation in metaplastic lesions
Supervisor
 Biomedicina (PhD)
Universidade do Porto Faculdade de Medicina, Portugal
2007/09/01 - 2008/07/31 Study of the CDX2 gene regulation in gastric cell lines – emphasis on transcription factors GATA-4/-5 and -6 and SOX2
Supervisor
 Bioquímica (Master)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2007/09/01 - 2008/06/30 Estudo de polimorfismos no locus do gene CDX2 em Portugal e Moçambique
Supervisor
 Medicina e Oncologia Molecular (Master)
Universidade do Porto Faculdade de Medicina, Portugal
2004/09/01 - 2005/06/30 Papel da proteína SMAD4 na activação da transcrição do gene CDX2 no contexto da Metaplasia Intestinal Gástrica
Supervisor
 Bioquímica (Degree)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal

Event organisation

Event name
Type of event (Role) 		Institution / Organization
2024/05/09 - 2024/05/10 XXX Porto Cancer Meeting - RNA biology in cancer: fundamentals and clinical relevance (2024/05/09 - 2024/05/10)
Conference (Member of the Organising Committee)
 Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal
2020/11/26 - 2020/11/27 Organoids without borders (2020/11/26 - 2020/11/27)
Conference (Co-organisor)
 Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal

Jury of academic degree

Topic
Role 		Candidate name (Type of degree)
Institution / Organization
2024/04/05 Gene Regulatory Mechanisms and miRNA in Colonic Epithelial Diseases
(Thesis) Main arguer
 Josephine Olsson (PhD)
Roskilde Universitet, Denmark
2023/04/02 Epigenetic regulation of non-coding RNAs in prostate cancer
(Thesis) Arguer
 Daniela Silva (PhD)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2021/12/14 m6ACODE: Deciphering the hidden message in m6A RNA methylation in Gastric Cancer
Supervisor
 Diana Ferreira (Master)
2021/12/02 Unravelling a cancer stem cell signature associated with breast cancer metastatic organotropism
(Thesis) Main arguer
 Inês Conde (Master)
Universidade do Porto Faculdade de Medicina, Portugal
2020/12/14 E-cadherin and CD44v6 in Gastric Cancer: Role, crosstalk and clinical implications
Thesis Member
 Carla Pereira (PhD)
2020/03/08 Impact of Host Glycosylation in Tuberculosis
Thesis Member
 Kaori da Fonseca (PhD)
2018/12/02 The relationship between naive pluripotency and X-chromosome inactivation
(Thesis) Arguer
 Elsa Sousa (PhD)
2018/09/01 In vitro generation of cholangiocyte-like cells from human liver organoids
(Thesis) Main arguer
 João Pedro Ferreira Faria (Master)
2017/09/01 Mechanisms of AXL mediated cell plasticity and drug resistance
(Thesis) Main arguer
 Stefan Hinz (PhD)
2017/02/01 Relevance of MUC1 splice variants in pancreatic carcinogenesis
(Thesis) Arguer
 Andreia Mota de Sousa (PhD)
2016/06/01 Clinical Implications and Regulation of Intestinal Stem Cell Markers in Colon Cancer
(Thesis) Main arguer
 Maiken Espersen (PhD)
2016/05/06 Mucins MUC16 and MUC1 are major carriers of SLea and SLex in borderline and malignant serous ovarian tumours
(Thesis) Main arguer
 Cristina Lara Valente (Master)
2016/02/01 In vivo evaluation of the role of DELTA-like 4/Notch signaling in the development of intestinal tumors
(Thesis) Main arguer
 Marina Martins Badenes (PhD)
2015/01/03 Health Communication: a new model to promote cancer prevention campaigns at schools
(Thesis) Arguer
 Ana Barros (PhD)
2014/12/05 Transcriptional Regulation of the Mannosyltransferase-encoding gene PIGM in inherited Glysosylphosphatidylinositol (GPI) deficiency
(Thesis) Arguer
 Joana R. S. da Costa (PhD)
2014/11/04 Dies1 gene expression and regulation in gastric cancer
(Thesis) Main arguer
 Inês Calado Reis (Master)
2014/11/03 Mucin MUC16 – CA125 cancer biomarker: biological functions and development of new biomarker assays
(Thesis) Arguer
 Lara Patrícia Marcos Silva (PhD)
2014/01/06 The role of CDX2 in inflammatory bowel disease
(Thesis) Main arguer
 Mehmet Coskun (PhD)
2013/09/06 Signaling pathways activated by inflammatory cytokines can regulate genes involved in gastric carcinogenesis
(Thesis) Main arguer
 Lara Cobler (PhD)
2013/05/29 Mecanismos moleculares do esófago de Barrett
(Thesis) Main arguer
 Isabel Saavedra (Master)
2012/11/06 The role of Rac1-modulated gene transcription in tumorigenesis
(Thesis) Main arguer
 Patrícia Alexandra Sousa Barros (PhD)
2012/05/11 Mecanismos de regulação da diferenciação intestinal normal e metaplásica
(Thesis) Main arguer
 Jaime Pereira Rodrigues (Master)
2010/03/01 Identification of the HNF4-Alpha and CDX2 regulatory network
(Thesis) Main arguer
 Mette Boyd (PhD)
2009/12/10 Expressão das proteínas da via Smad-dependente do TGF-Beta em carcinoma papilar da tiroide
(Thesis) Main arguer
 Joana Santos (Master)

Association member

Society Organization name Role
2012/06/01 - Current ASPIC Member of Fiscal Committee 2012-2016

Committee member

Activity description
Role 		Institution / Organization
2018 - Current Comissão de Acompanhamento do Mestrado em Biologia Celular e Molecular
Member
 Universidade do Porto Faculdade de Ciências, Portugal

Conference scientific committee

Conference name Conference host
2018/11/06 - 2018/11/06 Cancro colorretal em Portugal: da investigação à prevenção e ao tratamento Porto, Portugal
2017/11/09 - 2017/11/10 6th i3S Annual Meeting Póvoa de varzim, Portugal
2015/04/12 - 2015/04/13 XXIII Porto Cancer Meeting – Stem Cells and Cancer Porto, Portugal
2012/10/25 - 2012/10/25 Launching Meeting da Associação Portuguesa de Investigação em Cancro (ASPIC) – “One day with Carlos Caldas Porto, Portugal
2012/04/18 - 2012/04/20 International Meeting of the Portuguese Society for Stem Cells & Cell Therapies (7th SPCE-TC Meeting) Porto, Portugal
2010/04/28 - 2010/04/29 XIX Porto Cancer Meeting - Differentiation, Regeneration and Cancer Porto, Portugal

Evaluation committee

Activity description
Role 		Institution / Organization Funding entity
2024/10/06 - 2024/12/12 MSCA-PF 2024
Evaluator
 European Commission, Belgium
2023/10/05 - 2023/12/04 MSCA-PF 2023
Evaluator
 European Commission, Belgium
2023/04/01 - 2023/06/12 Horizon Europe Health-Mission Cancer
Evaluator
 European Commission, Belgium
2022/10/06 - 2022/12/02 MSCA-PF 2022
Evaluator
 European Commission, Belgium
2021/11/01 - 2022/01/31 MSCA-PF 2021
Evaluator
 European Commission, Belgium
2020/10/01 - 2020/12/10 Marie Sklodowska-Curie Individual Fellowships 2020
2019/10/01 - 2019/10/31 Marie Sklodowska-Curie Individual Fellowships 2019
Evaluator
 European Commission
2018/10/01 - 2018/12/31 Marie Sklodowska-Curie Individual Fellowships 2018
Evaluator
 European Commission

Journal scientific committee

Journal title (ISSN) Publisher
2017/12/01 - Current https://publons.com/researcher/1443811/raquel-almeida/

Mentoring / Tutoring

Topic Student name
2019/06/01 - 2019/09/30 Erasmus student: Identification of new biomarkers in gastric cancer - role of the epitranscriptome Elvia Valentini
Distinctions

Award

2022 Prémio Crioestaminal & SPCE-TC Regenerative Medicine Research Award